{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:51:52Z","timestamp":1784303512198,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03433-4","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T17:01:43Z","timestamp":1711040503000},"page":"2109-2115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-1171","authenticated-orcid":false,"given":"Miguel","family":"Borreg\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"1","key":"3433_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s Global Tuberculosis Report 2022. Lancet Microbe. 2023;4(1): e20. https:\/\/doi.org\/10.1016\/S2666-5247(22)00359-7.","journal-title":"Lancet Microbe"},{"issue":"10","key":"3433_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10): e1002152.","journal-title":"PLoS Med"},{"key":"3433_CR3","unstructured":"Informe epidemiol\u00f3gico sobre la situaci\u00f3n de la tuberculosis en Espa\u00f1a. A\u00f1o 2020. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III."},{"key":"3433_CR4","unstructured":"Plan para la prevenci\u00f3n y control de la tuberculosis en Espa\u00f1a. Marzo 2019. Ministerio de sanidad, consumo y bienestar social."},{"issue":"288","key":"3433_CR5","first-page":"20201635","volume":"2021","author":"JC Emery","year":"1943","unstructured":"Emery JC, Richards AS, Dale KD, McQuaid CF, White RG, Denholm JT, et al. Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease. Proc R Soc B. 1943;2021(288):20201635.","journal-title":"Proc R Soc B"},{"key":"3433_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5770","volume":"367","author":"MA Behr","year":"2019","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019;367: l5770.","journal-title":"BMJ"},{"issue":"4","key":"3433_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017601","volume":"6","author":"EW Tiemersma","year":"2011","unstructured":"Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS ONE. 2011;6(4): e17601.","journal-title":"PLoS ONE"},{"issue":"12","key":"3433_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.arbres.2016.05.002","volume":"52","author":"JA Gull\u00f3n","year":"2016","unstructured":"Gull\u00f3n JA, Garc\u00eda-Garc\u00eda JM, Villanueva M\u00c1, et al. Tuberculosis costs in Spain and related factors. Costes de la tuberculosis en Espa\u00f1a: factores relacionados. Arch Bronconeumol. 2016;52(12):583\u20139.","journal-title":"Arch Bronconeumol."},{"issue":"3","key":"3433_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3433_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353.","journal-title":"Int J Cancer"},{"key":"3433_CR11","unstructured":"REDECAN. Red Espa\u00f1ola de Registros de C\u00e1ncer. https:\/\/redecan.org\/es\/redecan. Accessed 10 Jan 2024."},{"key":"3433_CR12","unstructured":"Las cifras del c\u00e1ncer en Espa\u00f1a 2023. Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). ISBN: 978-84-09-48173-6."},{"issue":"3","key":"3433_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/17512433.2021.1884067","volume":"14","author":"BL Rapoport","year":"2021","unstructured":"Rapoport BL, Cooksley T, Johnson DB, Anderson R, Shannon VR. Treatment of infections in cancer patients: an update from the neutropenia, infection, and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC). Expert Rev Clin Pharmacol. 2021;14(3):295\u2013313.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"3433_CR14","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.129.6.1432","volume":"129","author":"PA Danai","year":"2006","unstructured":"Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432\u201340.","journal-title":"Chest"},{"issue":"1","key":"3433_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1753-6405.12935","volume":"44","author":"L Te Marvelde","year":"2020","unstructured":"Te Marvelde L, Whitfield A, Shepheard J, Read C, Milne RL, Whitfield K. Epidemiology of sepsis in cancer patients in Victoria, Australia: a population-based study using linked data. Aust N Z J Public Health. 2020;44(1):53\u20138.","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"3433_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/crj.12094","volume":"8","author":"A Christopoulos","year":"2014","unstructured":"Christopoulos A, Saif MW, Sarris EG, Syrigos KN. Epidemiology of active tuberculosis in lung cancer patients: a systematic review. Clin Respir J. 2014;8(4):375\u201381.","journal-title":"Clin Respir J"},{"key":"3433_CR17","doi-asserted-by":"crossref","unstructured":"Nanthanangkul S, Promthet S, Suwanrungruang K, Santong C, Vatanasapt P. Incidence of and risk factors for tuberculosis among cancer patients in endemic area: a Regional Cohort Study. Asian Pac J Cancer Prev. 2020;21(9):2715\u201321. Published 2020 Sep 1.","DOI":"10.31557\/APJCP.2020.21.9.2715"},{"key":"3433_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lungcan.2018.05.030","volume":"122","author":"JC Ho","year":"2018","unstructured":"Ho JC, Leung CC. Management of co-existent tuberculosis and lung cancer. Lung Cancer. 2018;122:83\u20137.","journal-title":"Lung Cancer"},{"issue":"1","key":"3433_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/ije\/30.1.118","volume":"30","author":"AV Brenner","year":"2001","unstructured":"Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province. China Int J Epidemiol. 2001;30(1):118\u201324.","journal-title":"China Int J Epidemiol"},{"key":"3433_CR20","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Lorenzo C, Garc\u00eda Gasalla M, Cifuentes Luna C, Payeras Cifre A. Neoplasias oncohematol\u00f3gicas y tuberculosis. Experiencia de un hospital general [Oncohematologic cancers and tuberculosis in a general hospital]. Enferm Infecc Microbiol Clin. 2016;34(2):143\u20134.","DOI":"10.1016\/j.eimc.2015.05.003"},{"issue":"12","key":"3433_CR21","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/ijc.24636","volume":"125","author":"HY Liang","year":"2009","unstructured":"Liang HY, Li XL, Yu XS, et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009;125(12):2936\u201344.","journal-title":"Int J Cancer"},{"issue":"9","key":"3433_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5588\/ijtld.14.0578","volume":"19","author":"C Morales-Garc\u00eda","year":"2015","unstructured":"Morales-Garc\u00eda C, Parra-Ruiz J, S\u00e1nchez-Mart\u00ednez JA, Delgado-Mart\u00edn AE, Amzouz-Amzouz A, Hern\u00e1ndez-Quero J. Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy. Int J Tuberc Lung Dis. 2015;19(9):1027\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"3433_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0218492320984881","volume":"29","author":"HW Abdelwahab","year":"2021","unstructured":"Abdelwahab HW, Elmaria MO, Abdelghany DA, et al. Screening of latent TB infection in patients with recently diagnosed bronchogenic carcinoma. Asian Cardiovasc Thorac Ann. 2021;29(3):208\u201313.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"3433_CR24","doi-asserted-by":"crossref","unstructured":"Shu CC, Liao KM, Chen YC, Wang JJ, Ho CH. The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse. Sci Rep. 2019;9(1):11901. Published 2019 Aug 15.","DOI":"10.1038\/s41598-019-48395-8"},{"key":"3433_CR25","doi-asserted-by":"crossref","unstructured":"Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J. 2017;50(2):1700157. Published 2017 Aug 24.","DOI":"10.1183\/13993003.00157-2017"},{"issue":"1","key":"3433_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","volume":"23","author":"R Wood","year":"2000","unstructured":"Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr. 2000;23(1):75\u201380.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3433_CR27","doi-asserted-by":"crossref","unstructured":"Tubach F, Salmon D, Ravaud P, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The Three-Year Prospective French Research Axed on Tolerance of Biotherapies registry [published correction appears in Arthritis Rheum. 2009 Aug;60(8):2540. Lorthololary, O [corrected to Lortholary, O]]. Arthritis Rheum. 2009;60(7):1884\u201394.","DOI":"10.1002\/art.24632"},{"key":"3433_CR28","doi-asserted-by":"crossref","unstructured":"Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management [published correction appears in Cancer. 2004 May 1;100(9):1993\u20134]. Cancer. 2004;100(2):228\u201337.","DOI":"10.1002\/cncr.11882"},{"issue":"3","key":"3433_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5455\/medarh.2017.71.212-214","volume":"71","author":"V Cukic","year":"2017","unstructured":"Cukic V. The association between lung carcinoma and tuberculosis. Med Arch. 2017;71(3):212\u20134.","journal-title":"Med Arch"},{"issue":"3","key":"3433_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3348\/kjr.2001.2.3.138","volume":"2","author":"YI Kim","year":"2001","unstructured":"Kim YI, Goo JM, Kim HY, Song JW, Im JG. Coexisting bronchogenic carcinoma and pulmonary tuberculosis in the same lobe: radiologic findings and clinical significance. Korean J Radiol. 2001;2(3):138\u201344.","journal-title":"Korean J Radiol"},{"issue":"5","key":"3433_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/oxfordjournals.jjco.a023240","volume":"26","author":"YM Chen","year":"1996","unstructured":"Chen YM, Chao JY, Tsai CM, Lee PY, Perng RP. Shortened survival of lung cancer patients initially presenting with pulmonary tuberculosis. Jpn J Clin Oncol. 1996;26(5):322\u20137.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"3433_CR32","first-page":"1002","volume":"13","author":"SI Cha","year":"2009","unstructured":"Cha SI, Shin KM, Lee JW, et al. The clinical course of respiratory tuberculosis in lung cancer patients. Int J Tuberc Lung Dis. 2009;13(8):1002\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"3433_CR33","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1086\/503917","volume":"42","author":"M Kamboj","year":"2006","unstructured":"Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42(11):1592\u20135.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3433_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2020.100643","volume":"45","author":"CK Nair","year":"2021","unstructured":"Nair CK, Avaronnan M, Shenoy PK, et al. Impact of active tuberculosis on treatment decisions in cancer. Curr Probl Cancer. 2021;45(2): 100643.","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"3433_CR35","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C De Martel","year":"2020","unstructured":"De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390.","journal-title":"Lancet Glob Health"},{"key":"3433_CR36","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1\u2013441."},{"issue":"9","key":"3433_CR37","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609\u201316.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"3433_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10654-017-0334-z","volume":"33","author":"KD Shield","year":"2018","unstructured":"Shield KD, MarantMicallef C, de Martel C, et al. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(3):263\u201374.","journal-title":"Eur J Epidemiol"},{"key":"3433_CR39","unstructured":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization; 2018. ISBN 978-92-4-155023-9."},{"issue":"24","key":"3433_CR40","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMcp2108501","volume":"385","author":"M Shah","year":"2021","unstructured":"Shah M, Dorman SE. Latent tuberculosis infection. N Engl J Med. 2021;385(24):2271\u201380.","journal-title":"N Engl J Med"},{"issue":"9","key":"3433_CR41","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2016.10357","volume":"316","author":"LC Kahwati","year":"2016","unstructured":"Kahwati LC, Feltner C, Halpern M, et al. Primary care screening and treatment for latent tuberculosis infection in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316(9):970\u201383.","journal-title":"JAMA"},{"issue":"5","key":"3433_CR42","doi-asserted-by":"publisher","first-page":"297.e1","DOI":"10.1016\/j.eimc.2010.02.006","volume":"28","author":"H Gonz\u00e1lez-Mart\u00edn","year":"2010","unstructured":"Gonz\u00e1lez-Mart\u00edn H, Garc\u00eda-Garc\u00eda JM, et al. Documento de consenso sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de la tuberculosis. Enferm Infecc Microbiol Clin. 2010;28(5):297.e1-297.e20.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3433_CR43","unstructured":"Testing and Treatment of latent tuberculosis infection in the United States: Clinical Recommendations. A guide for health care providers and public health programs. National Society of Tuberculosis Clinicians; 2021."},{"key":"3433_CR44","doi-asserted-by":"crossref","unstructured":"Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020;69(1):1\u201311. Published 2020 Feb 14.","DOI":"10.15585\/mmwr.rr6901a1"},{"issue":"56","key":"3433_CR45","first-page":"3865","volume":"10","author":"J La\u00ednez","year":"2010","unstructured":"La\u00ednez J, Mart\u00ednez MB, et al. Indicaciones de profilaxis y quimioprofilaxis de la tuberculosis. Medicine. 2010;10(56):3865\u20139.","journal-title":"Medicine"},{"key":"3433_CR46","unstructured":"Aguado JM, Almirante B, Fort\u00fan J. Tuberculosis. Protocolos cl\u00ednicos Sociedad espa\u00f1ola de enfermedades infecciosas y microbiolog\u00eda cl\u00ednica, Cap\u00edtulo VII."},{"key":"3433_CR47","doi-asserted-by":"crossref","unstructured":"Baden LR, Swaminathan S, Angarone M, et al. Prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(7):882\u2013913.","DOI":"10.6004\/jnccn.2016.0093"},{"issue":"30","key":"3433_CR48","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018;36(30):3043\u201354.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3433_CR49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s12094-022-02800-3","volume":"24","author":"I Echavarria","year":"2022","unstructured":"Echavarria I, Carri\u00f3n Galindo JR, Corral J, et al. SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021). Clin Transl Oncol. 2022;24(4):724\u201332.","journal-title":"Clin Transl Oncol"},{"key":"3433_CR50","unstructured":"Mariano Provencio Pulla; ESMO handbook of oncological emergencies; 2016; ISBN: 978-88-906359-9-1."},{"issue":"31","key":"3433_CR51","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1200\/JCO.20.01757","volume":"38","author":"JP Hwang","year":"2020","unstructured":"Hwang JP, Feld JJ, Hammond SP, et al. Hepatitis B Virus screening and management for patients with cancer prior to therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol. 2020;38(31):3698\u2013715.","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"3433_CR52","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.cmi.2018.02.009","volume":"24","author":"M Reinwald","year":"2018","unstructured":"Reinwald M, Silva JT, Mueller NJ, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors). Clin Microbiol Infect. 2018;24(Suppl 2):S53\u201370.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"3433_CR53","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.jtho.2016.07.006","volume":"11","author":"K Fujita","year":"2016","unstructured":"Fujita K, Terashima T, Mio T. Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis. J Thorac Oncol. 2016;11(12):2238\u201340.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"3433_CR54","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1164\/rccm.201807-1250LE","volume":"198","author":"PT Elkington","year":"2018","unstructured":"Elkington PT, Bateman AC, Thomas GJ, Ottensmeier CH. Implications of tuberculosis reactivation after immune checkpoint inhibition. Am J Respir Crit Care Med. 2018;198(11):1451\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3433_CR55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cmi.2017.12.003","volume":"24","author":"H Picchi","year":"2018","unstructured":"Picchi H, Mateus C, Chouaid C, et al. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment. Clin Microbiol Infect. 2018;24(3):216\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3433_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.21705","volume":"55","author":"SS Jick","year":"2006","unstructured":"Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid Use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006;55(1):19\u201326.","journal-title":"Arthritis Rheum"},{"key":"3433_CR57","doi-asserted-by":"crossref","unstructured":"Davis JS, Ferreira D, Paige E, Gedye C, Boyle M. Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev. 2020;33(3):e00035\u201319. Published 2020 Jun 10.","DOI":"10.1128\/CMR.00035-19"},{"issue":"12","key":"3433_CR58","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.3390\/curroncol29120731","volume":"29","author":"R Taha","year":"2022","unstructured":"Taha R, Kothari S, Foroutan F, et al. Implementation of a Routine Screening Program for latent tuberculosis infection among patients with acute leukemia at a Canadian Cancer Center. Curr Oncol. 2022;29(12):9325\u201334.","journal-title":"Curr Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03433-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T21:03:58Z","timestamp":1724101438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03433-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3433"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03433-4","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors of the manuscript declare that there is not any conflict of interest for its publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the authors of the manuscript declare that the ethical principles have been respected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors of the manuscript declare their consent to be reviewed and published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}